These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 9110913)
1. Contentious screening decisions: does the choice matter? Pauker SG; Kassirer JP N Engl J Med; 1997 Apr; 336(17):1243-4. PubMed ID: 9110913 [No Abstract] [Full Text] [Related]
2. Re: Public knowledge of benefits of breast and prostate cancer screening in Europe. Brenner H; Heywang-Köbrunner S; Becker N J Natl Cancer Inst; 2010 Mar; 102(5):356; author reply 356-7. PubMed ID: 20075365 [No Abstract] [Full Text] [Related]
3. Liability for failure to order screening examinations. Berlin L AJR Am J Roentgenol; 2002 Dec; 179(6):1401-5. PubMed ID: 12438024 [No Abstract] [Full Text] [Related]
4. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. Belpomme D; Irigaray P J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186 [No Abstract] [Full Text] [Related]
6. How did the PSA system arise? Justman S J R Soc Med; 2010 Aug; 103(8):309-12. PubMed ID: 20610619 [No Abstract] [Full Text] [Related]
7. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain. Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710 [TBL] [Abstract][Full Text] [Related]
8. The mammography and prostate-specific antigen controversies: implications for patient-physician encounters and public policy. Brett AS J Gen Intern Med; 1995 May; 10(5):266-70. PubMed ID: 7542328 [No Abstract] [Full Text] [Related]
10. Divergent Responses to Mammography and Prostate-Specific Antigen Recommendations. Martinez KA; Rothberg MB Am J Prev Med; 2017 Oct; 53(4):533-536. PubMed ID: 28318901 [No Abstract] [Full Text] [Related]
11. Lung cancer screening gets risk-specific. Peres J J Natl Cancer Inst; 2013 Jan; 105(1):1-2. PubMed ID: 23257155 [No Abstract] [Full Text] [Related]
12. What is the difference between screening and diagnostic tests? Johns Hopkins Med Lett Health After 50; 2002 Jul; 14(5):8. PubMed ID: 12154802 [No Abstract] [Full Text] [Related]
13. Chances and risks in medical risk communication. Hoffrage U; Koller M Ger Med Sci; 2015; 13():Doc07. PubMed ID: 26195920 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States: A Nationwide Survey Analysis. Abdollah F; Sun M; Sammon JD; Choueiri TK; Menon M; Weissman JS; Trinh QD JAMA Oncol; 2016 Apr; 2(4):543-5. PubMed ID: 26794060 [No Abstract] [Full Text] [Related]
15. Save your life: cancer screening is oversold. Know the tests to get--and those to skip. Consum Rep; 2013 Mar; 78(3):28-33. PubMed ID: 23556197 [No Abstract] [Full Text] [Related]
16. [Oncological screening in postmodern era]. Berrino F Epidemiol Prev; 2000; 24(1):15. PubMed ID: 10748543 [No Abstract] [Full Text] [Related]
18. Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective. Hayes JH; Barry MJ; Kantoff PW; Stahl JE BJU Int; 2007 Sep; 100(3):486-8. PubMed ID: 17669139 [No Abstract] [Full Text] [Related]
19. Best screening tests for prostate cancer. Moul JW West J Med; 1998 Aug; 169(2):109-10. PubMed ID: 9735692 [No Abstract] [Full Text] [Related]
20. Storm over screening for prostate specific antigen. Innuendo in article is insulting. Ward R BMJ; 2002 Jun; 324(7350):1392. PubMed ID: 12053923 [No Abstract] [Full Text] [Related] [Next] [New Search]